The remaining 2%–5% of cases are early‐onset AD (EOAD) that are linked to genetic mutation(s) in genes involved in amyloid metabolism, such as Amyloid Precursor Protein (APP), Presenilin 1 (PSEN1), and Presenilin 2 (PSEN2). The gene discussed is APP; the disease is Onset.